Experimental Whole-Virus Flu Vaccine Shows Safety and Broad Immune Signals in First Human Trial
A phase 1 trial found that the BPL-1357 whole-virus inactivated influenza vaccine was well tolerated and induced broad antibody responses ...
A phase 1 trial found that the BPL-1357 whole-virus inactivated influenza vaccine was well tolerated and induced broad antibody responses ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine